Loading clinical trials...
Loading clinical trials...
A Pilot Study to Assess Virologic Suppression and Immune Recovery With Raltegravir and Lopinavir/Ritonavir and Raltegravir and Emtricitabine/Tenofovir in HIV-1 Infected Treatment-naïve Subjects
Conditions
Interventions
Raltegravir & Lopinavir/ritonavir
Raltegravir and emtricitabine/tenofovir
Locations
1
United States
University of Miami AIDS Clinical Research Unit
Miami, Florida, United States
Start Date
April 1, 2008
Primary Completion Date
January 1, 2012
Completion Date
January 1, 2012
Last Updated
August 3, 2015
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
Margaret A. Fischl, M.D.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions